INIS
children
100%
indonesia
70%
adolescents
55%
schools
28%
vaccines
26%
interventions
25%
risks
24%
safety
23%
assessments
18%
patients
18%
covid-19
17%
correlations
17%
adults
17%
growth
16%
diseases
15%
hospitals
15%
validation
15%
control
14%
infants
14%
comparative evaluations
13%
doses
13%
populations
13%
psychological behavior
13%
pediatrics
13%
images
12%
data
12%
typhoid
11%
water
11%
levels
11%
intake
10%
quality of life
10%
reliability
9%
screening
9%
cities
9%
communities
8%
women
8%
clinical trials
8%
sleep
8%
inventories
8%
epilepsy
7%
toxoids
7%
proteins
7%
values
7%
beverages
6%
weight
6%
spectra
6%
therapy
6%
length
5%
surveillance
5%
detection
5%
Keyphrases
Indonesia
76%
Indonesian Adolescent
32%
Indonesian
26%
Immunogenicity
23%
Indonesian children
19%
Jakarta
19%
Malaysian Adults
16%
Randomized Controlled Trial
15%
Indonesian Version
15%
COVID-19 Pandemic
14%
Typhoid Vaccine
12%
Young children
11%
Vi-DT
11%
Body Image
10%
Quality of Life
10%
COVID-19
10%
Nutritional Status
9%
Developmental Delay
9%
School-based
8%
Safety Profile
8%
Behavioral Disorders
8%
Phase II Study
8%
Language Delay
8%
Second Dose
8%
Seroconversion
7%
Developmental Disorders
7%
Randomized Clinical Trial
7%
Under-five children
7%
Primary Infection
7%
Diphtheria Toxoid
7%
Urban Dwelling
7%
Seroprevalence
7%
Elementary School Students
7%
Attention Deficit Hyperactivity Disorder
7%
Dengue
7%
Indonesian Women
7%
Cross-cultural Validation
7%
Recombinant Vaccine
7%
Warna
7%
Cultural Adaptation
7%
High Risk
6%
Internal Consistency
6%
Behavior Problems
6%
Vaccination
6%
Age Groups
6%
Psychological Well-being
6%
Beverage Consumption
6%
Body Dissatisfaction
6%
Local Reaction
6%
Systemic Response
6%